|
DCAF13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.184600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.146400E-02 |
| Normal-vs-Stage2 |
2.179800E-01 |
| Normal-vs-Stage3 |
1.103030E-03 |
| Normal-vs-Stage4 |
1.898280E-02 |
| Stage1-vs-Stage2 |
8.111000E-01 |
| Stage1-vs-Stage3 |
9.618100E-02 |
| Stage1-vs-Stage4 |
2.366200E-01 |
| Stage2-vs-Stage3 |
1.973950E-01 |
| Stage2-vs-Stage4 |
3.114800E-01 |
| Stage3-vs-Stage4 |
9.613200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.639500E-03 |
| Normal-vs-AfricanAmerican |
1.337980E-01 |
| Normal-vs-Asian |
2.846200E-02 |
| Caucasian-vs-AfricanAmerican |
9.844600E-01 |
| Caucasian-vs-Asian |
7.960000E-01 |
| AfricanAmerican-vs-Asian |
8.647800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.000100E-04 |
| Normal-vs-Female |
1.642090E-02 |
| Male-vs-Female |
8.078200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.019600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.391000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.486300E-02 |
| Normal-vs-Age(81-100Yrs) |
9.987200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.260000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.084400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.956000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.666000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.214400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.562410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.287000E-01 |
| Classical-VS-Follicular |
5.741900E-02 |
| Classical-VS-Other |
2.577800E-01 |
| Classical-VS-Normal |
7.101900E-02 |
| Tall-VS-Follicular |
6.975800E-01 |
| Tall-VS-Other |
5.124400E-01 |
| Tall-VS-Normal |
5.633700E-02 |
| Follicular-VS-Other |
6.798200E-01 |
| Follicular-VS-Normal |
4.962000E-03 |
| Other-VS-Normal |
1.821050E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.178810E-03 |
| Normal-vs-N1 |
3.979300E-03 |
| N0-vs-N1 |
2.763800E-01 |
|
|
